Tumor-infiltrating B cells are emerging as key players in cancer immunity, capable of exerting both pro- and anti-tumor effects through diverse mechanisms—including cytokine secretion, modulation of CD8+ T cell function, and production of tumor-specific antibodies—depending on the tumor context [82]. The gene discussed is CD8A; the disease is neoplasm.